Tyson Foods quietly invested in 5 more plant-protein startups this year while publicly doubling down on beef

Tyson Foods spent the first half of 2025 doing what Tyson Foods does best: talking about beef. CEO Donnie King appeared at industry conferences praising the resilience of American cattle ranching. The company's Super Bowl-adjacent ad campaign featured slow-motion shots of sizzling patties. Their Q1 earnings call mentioned "beef" 47 times and "plant-based" exactly zero.

\p>Meanwhile, according to filings and industry disclosures reviewed by multiple trade outlets, Tyson's venture arm has quietly poured capital into at least five plant-protein and alternative-protein startups since January. The investments span fermentation technology, mycelium-based proteins, and precision agriculture platforms designed to make plant-protein sourcing cheaper at scale.

If you're getting mixed signals, you're paying attention.

The Five Investments We Know About

Tyson Ventures, the company's corporate venture capital arm, has been operational since 2016. It previously held a stake in Beyond Meat (which it divested before the IPO) and has invested in Memphis Meats (now Upside Foods), Future Meat Technologies, and the Israeli mycoprotein company Mush Foods.

The 2025 portfolio additions, pieced together from SEC filings, press releases from the startups themselves, and reporting by AgFunder News and the Food Institute, include:

1. A fermentation-based protein startup working on producing casein and whey analogs without cows. The company, based in the Research Triangle area of North Carolina, reportedly received a Series A round with Tyson Ventures participating alongside two other strategic food-industry investors.

2. A mycelium platform company that grows whole-cut meat alternatives using fungal fermentation in bioreactors. The company claims its process uses 90% less water than conventional beef production, a metric that has become the gold standard for alternative-protein pitch decks ever since climate scientists started ranking foods by water cost per gram of protein.

3. A precision agriculture company focused on optimizing pea and soy protein yields for food-grade applications. This one is arguably the most telling investment of the bunch. It suggests Tyson is looking at the supply-chain fundamentals of plant protein, not just the flashy consumer-facing products.

4. A snack-food brand using proprietary protein blends (pea, fava bean, chickpea) to create high-protein, shelf-stable snack bars and puffs targeting the convenience channel.

5. A cultivated-fat startup working on growing animal fat cells in bioreactors to add to plant-based products. The theory: most of what makes meat taste like meat is the fat, and cultured fat could be the missing puzzle piece for the next generation of plant-forward products. As VegOut previously covered, the line between plant-based and cell-cultivated is blurring fast, and companies like this one sit right at the intersection.

Tyson declined to comment on specific venture investments for this article, pointing instead to a general statement on their website about maintaining "a diversified approach to meeting evolving consumer protein needs."

Corporate-speak for: we're hedging.

Why the Quiet Part Matters

There's a reason Tyson isn't holding press conferences about these moves. The politics of protein in America have calcified in ways that would've seemed absurd a decade ago. Beef has become a cultural signifier. State legislatures are passing laws restricting the labeling of plant-based products. The word "meat" itself has become contested legal territory in multiple jurisdictions.

For Tyson, a company whose core customer base skews toward conventional meat buyers in Middle America, loudly championing alt-protein would be a marketing own-goal. But ignoring the sector entirely would be a strategic one.

So they do both. Loudly beef. Quietly plants.

This playbook has historical precedent. Big Tobacco companies invested in vaping long before they talked about it publicly. Oil majors have held renewable-energy patents for decades while their ad campaigns featured drilling rigs and hard hats. The pattern is consistent: legacy industries fund their potential successors while publicly affirming their core business identity.

The question, as always, is whether the investments represent genuine strategic conviction or portfolio insurance they'd happily let expire.

The Context: A Plant-Based Market in Flux

Tyson's dual strategy makes more sense when you look at the current state of plant-based protein, which is simultaneously struggling and evolving.

On the struggle side: Beyond Meat's stock hit an all-time low earlier this year, and the first wave of plant-based meat hype has clearly deflated. Retail sales of refrigerated plant-based meat alternatives declined for the third consecutive year, according to data from SPINS and the Good Food Institute. The "I tried the Impossible Whopper once" era is over.

But the evolution side tells a different story. Impossible Foods quietly reformulated its burger again and landed better blind-test results against beef. Fermentation-based proteins are attracting serious R&D money. Singapore continues to fast-track cultivated meat approvals, creating a real-world regulatory template. And as we reported recently, Gen Z may not be reaching for plant-based burgers, but they're pouring money into fermented foods, signaling that the demand for alternative proteins is shifting rather than disappearing.

Tyson's venture team appears to be reading these same tea leaves. Their 2025 investments lean heavily toward next-generation approaches — fermentation, cultivated fat, agricultural infrastructure — rather than the first-gen pea protein burger model that has cooled off at retail.

Follow the Money, Not the Marketing

Tom Ackerman, a food-industry analyst at Rabobank, put it well in a recent industry presentation: "What a food company says in its ad budget and what it says in its venture portfolio are often two completely different narratives. The ad budget tells you what they're selling today. The venture portfolio tells you what they think they'll be selling in 2035."

Tyson's 2035 portfolio, based on the evidence, includes a significant alt-protein component. And they're not alone. Cargill, JBS, and Smithfield have all made similar quiet investments over the past few years while maintaining bullish public positions on conventional animal agriculture.

This isn't hypocrisy, exactly. It's more like corporate bilingualism. These companies speak "tradition" to their current customers and "innovation" to their investors and future selves. The tension between those two languages will eventually need to resolve, but for now, the biggest players in animal agriculture are comfortable holding the contradiction.

What makes Tyson's case particularly interesting is the scale. With $53 billion in annual revenue, even modest venture investments give them enormous optionality. A $5 million check into a fermentation startup barely registers on their balance sheet. But if that startup cracks a scalable, cost-competitive protein source in five years, Tyson has a front-row seat and likely preferential terms for licensing, acquisition, or partnership.

It's a cheap lottery ticket with potentially enormous upside. And they're buying a lot of them.

What This Means for the Future of Food

The optimistic read: Tyson's investments signal that even the most traditional corners of the protein industry see the future food landscape diversifying significantly. When the world's second-largest meat processor keeps writing checks to plant and fermentation startups, it validates the thesis that alternative proteins have real long-term commercial potential, current retail headwinds notwithstanding.

The skeptical read: Corporate venture investments are famously low-commitment. Companies make them for competitive intelligence as much as for returns. Tyson having a board observer seat at a cultivated-fat startup gives them visibility into a potential disruptor, which is valuable whether or not they ever actually want that technology to succeed. Some critics in the alternative-protein community have suggested that Big Meat invests in startups partly to slow them down or absorb them before they become competitive threats. There's no public evidence of this, but the suspicion persists.

The pragmatic read, which is probably closest to reality: Tyson is a publicly traded company with fiduciary obligations to shareholders. They will sell beef as long as beef is profitable. They will invest in alternatives as long as alternatives represent asymmetric upside. The moment the economics tip, the marketing will follow. They don't have a moral position on protein. They have a financial one.

And honestly? That might be exactly what the alternative-protein sector needs right now. The industry's first decade was powered by mission-driven founders and idealistic venture capital. The next decade will be powered by infrastructure, supply chains, and distribution networks that only companies like Tyson can provide. The marriage will be uncomfortable. It will also probably be necessary.

The Bigger Picture

We tend to think of food transitions as consumer-driven revolutions. People decide they want something different, and the market responds. But the history of food tells a more complicated story. Most major shifts in what we eat have been driven by supply-side economics, agricultural policy, and corporate strategy at least as much as by consumer preference.

Tyson quietly backing five more alt-protein startups while publicly celebrating beef is a perfect snapshot of where we are in 2025. The old system and the new system coexist, often inside the same company, sometimes inside the same quarterly report. The transition is happening, but it's happening in venture term sheets and R&D budgets, not (yet) in Super Bowl ads.

For anyone watching the future of protein — whether you eat meat every day, never, or somewhere in between — the move to track is money, not messaging. And Tyson's money is speaking plenty loud, even when their marketing department isn't.

Feature image by Mustafa Akın on Pexels